80
Views
31
CrossRef citations to date
0
Altmetric
Original Research

Increased adherence eight months after switch from twice daily calcineurin inhibitor based treatment to once daily modified released tacrolimus in heart transplantation

, , , , , , , & show all
Pages 1253-1258 | Published online: 21 Oct 2013

References

  • Abecassis MM Seifeldin R Riordan ME Patient outcomes and economics of once-daily tacrolimus in renal transplant patients: results of a modeling analysis Transplant Proc 2008 40 5 1443 1445 18589126
  • Alloway R Steinberg S Khalil K Conversion of stable kidney transplant recipients from a twice daily Prograf-based regimen to a once daily modified release tacrolimus-based regimen Transplant Proc 2005 37 2 867 870 15848559
  • Alloway R Steinberg S Khalil K Two years postconversion from a prograf-based regimen to a once-daily tacrolimus extended-release formulation in stable kidney transplant recipients Transplantation 2007 83 12 1648 1651 17589351
  • Diez Ojea B Alonso Alvarez M Aguado Fernández S Baños Gallardo M García Melendreras S Gómez Huertas E Three-month experience with tacrolimus once-daily regimen in stable renal allografts Transplant Proc 2009 41 6 2323 2325 19715908
  • First MR Fitzsimmons WE Modified release tacrolimus Yonsei Med J 2004 45 6 1127 1131 15627307
  • Florman S Alloway R Kalayoglu M Conversion of stable liver transplant recipients from a twice-daily Prograf-based regimen to a once-daily modified release tacrolimus-based regimen Transplant Proc 2005 37 2 1211 1213 15848672
  • Florman S Alloway R Kalayoglu M Once-daily tacrolimus extended release formulation: experience at 2 years postconversion from a Prograf-based regimen in stable liver transplant recipients Transplantation 2007 83 12 1639 1642 17589349
  • Heffron TG Pescovitz MD Florman S Once-daily tacrolimus extended-release formulation: 1-year post-conversion in stable pediatric liver transplant recipients Am J Transplant 2007 7 6 1609 1615 17511684
  • Silva HT Yang HC Abouljoud M One-year results with extended-release tacrolimus/MMF, tacrolimus/MMF and cyclosporine/MMF in de novo kidney transplant recipients Am J Transplant 2007 7 3 595 608 17217442
  • Gasparyan AY Ayvazyan L Cocco G Kitas GD Adverse cardiovascular effects of antirheumatic drugs: implications for clinical practice and research Curr Pharm Des 2012 18 11 1543 1555 22364138
  • Claxton AJ Cramer J Pierce C A systematic review of the associations between dose regimens and medication compliance Clin Ther 2001 23 8 1296 1310 11558866
  • Doesch AO Mueller S Konstandin M Increased adherence after switch from twice daily calcineurin inhibitor based treatment to once daily modified released tacrolimus in heart transplantation: a pre-experimental study Transplant Proc 2010 42 10 4238 4242 21168673
  • De Geest S Abraham I Dunbar-Jacob J Measuring transplant patients’ compliance with immunosuppressive therapy West J Nurs Res 1996 18 5 595 605 8918210
  • Dobbels F Berben L De Geest S Transplant 360 Task Force The psychometric properties and practicability of self-report instruments to identify medication nonadherence in adult transplant patients: a systematic review Transplantation 2010 90 2 205 219 20531073
  • Glass TR De Geest S Hirschel B Swiss HIV Cohort Study Self-reported non-adherence to antiretroviral therapy repeatedly assessed by two questions predicts treatment failure in virologically suppressed patients Antivir Ther (Lond) 2008 13 1 77 85 18389901
  • Deschamps AE De Geest S Vandamme AM Bobbaers H Peetermans WE Van Wijngaerden E Diagnostic value of different adherence measures using electronic monitoring and virologic failure as reference standards AIDS Patient Care STDS 2008 22 9 735 743 18754705
  • Kofler S Bigdeli AK Kaczmarek I Long-term outcomes after 1000 heart transplantations in six different eras of innovation in a single center Transpl Int 2009 22 12 1140 1150 19891043
  • Dösch AO Ehlermann P Koch A Remppis A Katus HA Dengler TJ A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens Clin Ther 2006 28 6 893 905 16860172
  • Haynes RB Ackloo E Sahota N McDonald HP Yao X Interventions for enhancing medication adherence Cochrane Database Syst Rev 2008 2 CD000011 18425859